Advertisement

GI & Endoscopy

Advertisement

A study found that while the long-term risks for recurrent acute diverticulitis are limited after colectomy, medically treated patients have similar outcomes, according to findings published in the British Journal of Surgery.

The FDA's Gastroenterology-Urology Devices Panel voted unanimously that LINX's Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a favorable risk-benefit profile and was safe and effective, according to an FDA report.

The number of gastric banding procedures has increased 22 times since the early 1990s and is expected to help drive the gastrointestinal device market to $14.6 billion, according to Kalorama Information's The World Market for Gastrointestinal Devices report.

Advertisement